ImmunityBio Inc. (IBRX:NASDAQ) rocketted at $1.84, a gain of 36.3%. On Tue, Mar 21, 2023, IBRX:NASDAQ hit a New 2-Week High of $1.84. From Tue, Mar 07, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Dec 13, 2022 at $7.1 with a volume of 3M+.
About ImmunityBio Inc. (IBRX:NASDAQ)
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
Top 10 Gainers:
- U.S. Xpress Enterprises, Inc. (USX:NYSE), 298.67%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 92.31%
- Impac Mortgage Holdings, Inc. (IMH:NYSEMKT), 89.81%
- Quince Therapeutics Inc Com (QNCX:NASDAQ), 71.1%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 59.88%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 39.48%
- ImmunityBio Inc. (IBRX:NASDAQ), 36.3%
- Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ), 35.77%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 35.65%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 33.33%